Search Results - "Chippalkatti, Rohan"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    RAS isoform specific activities are disrupted by disease associated mutations during cell differentiation by Chippalkatti, Rohan, Parisi, Bianca, Kouzi, Farah, Laurini, Christina, Ben Fredj, Nesrine, Abankwa, Daniel Kwaku

    Published in European journal of cell biology (01-06-2024)
    “…The RAS-MAPK-pathway is aberrantly regulated in cancer and developmental diseases called RASopathies. While typically the impact of Ras on the proliferation of…”
    Get full text
    Journal Article
  2. 2

    Mms19 promotes spindle microtubule assembly in Drosophila neural stem cells by Chippalkatti, Rohan, Egger, Boris, Suter, Beat

    Published in PLoS genetics (19-11-2020)
    “…Mitotic divisions depend on the timely assembly and proper orientation of the mitotic spindle. Malfunctioning of these processes can considerably delay…”
    Get full text
    Journal Article
  3. 3

    A flow-cytometry-based pipeline for the rapid quantification of C2C12 cell differentiation by Parisi, Bianca, Sünnen, Maxime, Chippalkatti, Rohan, Abankwa, Daniel Kwaku

    Published in STAR protocols (15-12-2023)
    “…The C2C12 cell line represents a simple in vitro model for cell differentiation. Here, we present a flow-cytometry-based pipeline to quantitate C2C12 cell…”
    Get full text
    Journal Article
  4. 4

    Promotion of cancer cell stemness by Ras by Chippalkatti, Rohan, Abankwa, Daniel

    Published in Biochemical Society transactions (26-02-2021)
    “…Cancer stem cells (CSC) may be the most relevant and elusive cancer cell population, as they have the exquisite ability to seed new tumors. It is plausible,…”
    Get more information
    Journal Article
  5. 5

    Drug targeting opportunities en route to Ras nanoclusters by Pavic, Karolina, Chippalkatti, Rohan, Abankwa, Daniel

    Published in Advances in cancer research (2022)
    “…Disruption of the native membrane organization of Ras by the farnesyltransferase inhibitor tipifarnib in the late 1990s constituted the first indirect approach…”
    Get full text
    Journal Article
  6. 6
  7. 7

    ERK regulates mitochondrial membrane potential in fission deficient Drosophila follicle cells during differentiation by Tomer, Darshika, Chippalkatti, Rohan, Mitra, Kasturi, Rikhy, Richa

    Published in Developmental biology (01-02-2018)
    “…Mitochondrial morphology regulatory proteins interact with signaling pathways involved in differentiation. In Drosophila oogenesis, EGFR signaling regulates…”
    Get full text
    Journal Article
  8. 8

    Dual Drug Conjugated Nanoparticle for Simultaneous Targeting of Mitochondria and Nucleus in Cancer Cells by Mallick, Abhik, More, Piyush, Ghosh, Sougata, Chippalkatti, Rohan, Chopade, Balu A, Lahiri, Mayurika, Basu, Sudipta

    Published in ACS applied materials & interfaces (15-04-2015)
    “…Effective targeting of mitochondria has emerged as an alternative strategy in cancer chemotherapy. However, considering mitochondria’s crucial role in cellular…”
    Get full text
    Journal Article
  9. 9

    Novel platinum-palladium bimetallic nanoparticles synthesized by Dioscorea bulbifera: anticancer and antioxidant activities by Ghosh, Sougata, Nitnavare, Rahul, Dewle, Ankush, Tomar, Geetanjali B, Chippalkatti, Rohan, More, Piyush, Kitture, Rohini, Kale, Sangeeta, Bellare, Jayesh, Chopade, Balu A

    Published in International journal of nanomedicine (01-01-2015)
    “…Medicinal plants serve as rich sources of diverse bioactive phytochemicals that might even take part in bioreduction and stabilization of phytogenic…”
    Get full text
    Journal Article
  10. 10

    Abstract 3493: Drug targeting of KRAS accumulation on the cilium inhibits its stemness driving activity by Kaya, Pelin, Chippalkatti, Rohan, Schaffner-Reckinger, Elisabeth, Parisi, Bianca, Manoharan, Ganesh B., Rouzbahani, Yashar, Eggeling, Christian, Abankwa, Daniel

    Published in Cancer research (Chicago, Ill.) (04-04-2023)
    “…Abstract Most RAS drug targeting strategies focus on KRAS, due to the high KRAS mutation frequency in cancer and its high expression level. Moreover, KRAS4B…”
    Get full text
    Journal Article